Observational studyClinics (Sao Paulo, Brazil)2024

Effects of Apatinib combined with Temozolomide on levels of sPD-1 and sPD-L1 in patients with drug-resistant recurrent glioblastoma.

Ren Zhao Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.